717 related articles for article (PubMed ID: 33387977)
1. Homegrown perceptions about the medical use and potential abuse of CBD and THC.
McFadden BR; Malone T
Addict Behav; 2021 Apr; 115():106799. PubMed ID: 33387977
[TBL] [Abstract][Full Text] [Related]
2. Copper Stimulation of Tetrahydrocannabinol and Cannabidiol Production in Hemp (
Cahill MS; Arsenault T; Bui TH; Zuverza-Mena N; Bharadwaj A; Prapayotin-Riveros K; White JC; Dimkpa CO
J Agric Food Chem; 2024 Apr; 72(13):6921-6930. PubMed ID: 38516700
[TBL] [Abstract][Full Text] [Related]
3. A new Cannabis genome assembly associates elevated cannabidiol (CBD) with hemp introgressed into marijuana.
Grassa CJ; Weiblen GD; Wenger JP; Dabney C; Poplawski SG; Timothy Motley S; Michael TP; Schwartz CJ
New Phytol; 2021 May; 230(4):1665-1679. PubMed ID: 33521943
[TBL] [Abstract][Full Text] [Related]
4. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
Hammond D; Goodman S
Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
[No Abstract] [Full Text] [Related]
5. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
[TBL] [Abstract][Full Text] [Related]
6. Current Cannabidiol Safety: A Review.
Singh C; Rao K; Yadav N; Vashist Y; Chugh P; Bansal N; Minocha N
Curr Drug Saf; 2023; 18(4):465-473. PubMed ID: 36056846
[TBL] [Abstract][Full Text] [Related]
7. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
[TBL] [Abstract][Full Text] [Related]
8. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cannabidiol (CBD) and THC in nonprescription consumer products: Implications for patients and practitioners.
Miller OS; Elder EJ; Jones KJ; Gidal BE
Epilepsy Behav; 2022 Feb; 127():108514. PubMed ID: 34998268
[TBL] [Abstract][Full Text] [Related]
11. Chemical profiling of Cannabis varieties cultivated for medical purposes in southeastern Brazil.
Carvalho VM; de Almeida FG; de Macêdo Vieira AC; Rocha ED; Cabral LM; Strongin RM
Forensic Sci Int; 2022 Jun; 335():111309. PubMed ID: 35462181
[TBL] [Abstract][Full Text] [Related]
12. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
Mead A
Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
[TBL] [Abstract][Full Text] [Related]
13. Substituting Cannabidiol for Opioids and Pain Medications Among Individuals With Fibromyalgia: A Large Online Survey.
Boehnke KF; Gagnier JJ; Matallana L; Williams DA
J Pain; 2021 Nov; 22(11):1418-1428. PubMed ID: 33992787
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Action and Pharmacokinetics of Cannabis.
Chayasirisobhon S
Perm J; 2020 Dec; 25():1-3. PubMed ID: 33635755
[TBL] [Abstract][Full Text] [Related]
15. Δ9-Tetrahydrocannabinol and Cannabidiol Time Courses in the Sera of "Light Cannabis" Smokers: Discriminating Light Cannabis Use from Illegal and Medical Cannabis Use.
Pichini S; Mannocchi G; Berretta P; Zaami S; Pirani F; Pacifici R; Busardò FP
Ther Drug Monit; 2020 Feb; 42(1):151-156. PubMed ID: 31389860
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Cannabidiol on Psychiatric and Medical Conditions.
Oberbarnscheidt T; Miller NS
J Clin Med Res; 2020 Jul; 12(7):393-403. PubMed ID: 32655732
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ
Peters EN; MacNair L; Mosesova I; Christians U; Sempio C; Klawitter J; Land MH; Ware MA; Turcotte C; Bonn-Miller MO
Eur J Clin Pharmacol; 2022 Feb; 78(2):259-265. PubMed ID: 34664109
[TBL] [Abstract][Full Text] [Related]
18. Effects of cannabidiol in cannabis flower: Implications for harm reduction.
Gibson LP; Karoly HC; Ellingson JM; Klawitter J; Sempio C; Squeri JE; Bryan AD; Bidwell LC; Hutchison KE
Addict Biol; 2022 Jan; 27(1):e13092. PubMed ID: 34467598
[TBL] [Abstract][Full Text] [Related]
19. Portable biosensors for rapid on-site determination of cannabinoids in cannabis, a review.
Harpaz D; Bernstein N; Namdar D; Eltzov E
Biotechnol Adv; 2022 Dec; 61():108031. PubMed ID: 36058440
[TBL] [Abstract][Full Text] [Related]
20. Comment on Lachenmeier
Kruse D; Beitzke B
F1000Res; 2020; 9():900. PubMed ID: 32864108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
